Advertisement
Musculoskeletal Report
July 04, 2009
MSK Report Video Podcasts

Meeting Highlights

ISEMIR 2009: Video coverage of the Meeting
Miami, March 27, 2009
RWCS 2009: Video coverage of the Symposium
Maui, January 14-17, 2009
ACR 2008: News from the Annual Scientific Meeting
San Francisco, October 24-29, 2008
EULAR 2008: Coverage of the Congress
Paris, June 11-14, 2008
ISEMIR 2008: Video coverage of the Meeting
Chicago, April 10, 2008
AAOS 2008: News from the Annual Meeting
San Francisco, March 5-9, 2008
ACR 2007: News from the Annual Scientific Meeting
Boston, November 6-11, 2007
ASBMR 2007: News from the national meeting
Honolulu, September 14-19, 2007
EULAR 2007: Coverage of the Congress
Barcelona, June 13-16, 2007

Affiliations

Arthritis Research
Lupus Research Institute - Letting Science Lead the Way to a Cure
RSS Feeds


Arthritis News

Lung Study Questions Leflunomide Safety in RA
Rheumatologists who routinely use leflunomide in rheumatoid arthritis patients should be on the look-out for early signs of lung disease...

Masitinib Pilot Study Shows Promise in DMARD-resistant RA
The first drug to target mast cells in RA shows promising early results in an uncontrolled phase 2a trial...

Gum Disease Prominent in RA, but TNF-Blockade Can Help
Three new studies shed light on the connection between rheumatoid arthritis (RA) and periodontitis, and new data help define a role for TNF-blockade in improving periodontal status as well as RA signs and symptoms...

Pegloticase Shrinks Tophi Even in Resistant Gout
Pegloticase significantly reduced tophus size in 40% of treatment-failure gout patients...

RA Rituxan Response Seen Best with High Res US
High resolution grey-scale ultrasonography may help rheumatologists measure response to rituximab treatment in rheumatoid arthritis (RA) patients...

IL-Blockade with Canakinumab Effective, Safe in JIA
Phase II data show that canakinumab (ACZ885) seems effective and safe in children with systemic juvenile idiopathic arthritis...

EULAR Studies Show New Picture of B-Cell Depletion in RA
A group of studies reported at EULAR show that B-cell depletion is a relatively safe and effective treatment option for patients with rheumatoid arthritis (RA)...

EULAR Report Shows Tocilizumab Protects Joints in RA
Actemra® maintained structure and function in a wide range of RA patients in the LITHE study, with response durations of 2 years in interim analyses...

Golimumab for Psoriatic Arthritis Still Effective at 2 Years
2-Year GO-REVEAL data show durable PsA response to golimumab...

RA Bone Changes May Offer New Treatment Target
Osteoporosis and erosions appear loosely linked in some RA patients...

Result Page:  (   [ 1 ]   2   3   4   5   6   7   ... 66  )   Next »